iBio (IBIO) Operating Leases (2021 - 2026)
iBio (IBIO) posted quarterly Operating Leases of $1.8 million for Q1 2026, down 22.88% year-over-year from $2.3 million in Q1 2025, and down 7.19% quarter-over-quarter from $1.9 million in Q4 2025.
iBio (IBIO) Operating Leases (2021 - 2026) Analysis & Trends
iBio (IBIO) has reported Operating Leases for 6 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 22.88% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 22.88% YoY), while the FY2025 annual figure was $2.2 million, down 18.19% from the prior year.
- Operating Leases declined to $1.8 million in Q1 2026 per IBIO's latest filing, from $1.9 million in the prior quarter.
- Across five years, Operating Leases topped out at $5.5 million in Q1 2022 and bottomed at $1.8 million in Q1 2026.
- Historically, Operating Leases has averaged $2.9 million across 5 years, with a median of $2.8 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Leases declined 1.01% — and 2023, when it sank 41.87%.
- iBio's Operating Leases stood at $3.3 million in 2022, then slipped by 12.39% to $2.9 million in 2023, then retreated by 15.87% to $2.4 million in 2024, then fell by 21.14% to $1.9 million in 2025, then fell by 7.19% to $1.8 million in 2026.
- Business Quant data shows IBIO's Operating Leases at $1.8 million in Q1 2026, $1.9 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | iBio | 175.21 Mn | 175.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 3.42 Mn |
| Jun 30, 2022 | 3.51 Mn |
| Mar 31, 2022 | 5.55 Mn |
| Dec 31, 2021 | 5.40 Mn |
| Sep 30, 2021 | 3.46 Mn |